Ronald Blue Trust, Inc. Vaxart, Inc. Transaction History
Ronald Blue Trust, Inc.
- $8.31 Billion
- Q2 2025
A detailed history of Ronald Blue Trust, Inc. transactions in Vaxart, Inc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 160 shares of VXRT stock, worth $60. This represents 0.0% of its overall portfolio holdings.
Number of Shares
160Holding current value
$60% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VXRT
# of Institutions
106Shares Held
27.4MCall Options Held
14.3KPut Options Held
55.2K-
Vanguard Group Inc Valley Forge, PA10.4MShares$3.96 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY5.58MShares$2.12 Million0.86% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$884,0200.0% of portfolio
-
Black Rock Inc. New York, NY1.77MShares$674,2510.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny956KShares$363,2290.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $48.1M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...